{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:26:49Z","timestamp":1789270009834,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54GM104942-03"],"award-info":[{"award-number":["U54GM104942-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM104942-03"],"award-info":[{"award-number":["U54GM104942-03"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.addbeh.2020.106752","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:27:31Z","timestamp":1607023651000},"page":"106752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["High prevalence of co-occurring substance use in individuals with opioid use disorder"],"prefix":"10.1016","volume":"114","author":[{"suffix":"III","given":"James J.","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Marshalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc W.","family":"Haut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Marton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley D.","family":"Kimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Armistead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Hodder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.addbeh.2020.106752_b0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.addbeh.2020.106752_b0010","unstructured":"American Society for Addiction Medicine. Drug Testing: A White Paper of the American Society of Addiction Medicine. (2013) Chevy Chase, MD."},{"issue":"7","key":"10.1016\/j.addbeh.2020.106752_b0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/add.13339","article-title":"Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies","volume":"111","author":"Betts","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2020.106752_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2015.06.020","article-title":"Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?","volume":"154","author":"Betts","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2020.106752_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.2011.10101476","article-title":"Risk of death from accidental overdose associated with psychiatric and substance use disorders","volume":"169","author":"Bohnert","year":"2012","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2020.106752_b0030","unstructured":"Center for Behavioral Health Statistics and Quality (2019). 2018 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration."},{"issue":"2","key":"10.1016\/j.addbeh.2020.106752_b0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"16","key":"10.1016\/j.addbeh.2020.106752_b0040","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.addbeh.2020.106752_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: The surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2020.106752_b0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.addbeh.2020.106752_b0055","doi-asserted-by":"crossref","unstructured":"Griggs, C., Wyatt, S., Wally, M.K., Runyon, M., Hsu, J.R., Seymour, R.B., Beuhler, M., Bosse, M.J., Fogg, R., Gibbs, M., Haas, E., Jarrett, S., Leas, D., Saha, A., Schiro, S., Watling, B., PRIMUM Group (2019). Prescribing of Opioids and Benzodiazepines Among Patients with History of Overdose. J. Addict. Med. 13, 396-402.","DOI":"10.1097\/ADM.0000000000000513"},{"issue":"3","key":"10.1016\/j.addbeh.2020.106752_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.chc.2016.02.005","article-title":"Objective Testing: Urine and Other Drug Tests","volume":"25","author":"Hadland","year":"2016","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.addbeh.2020.106752_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2019.01.031","article-title":"Polydrug use disorders in individuals with opioid use disorder","volume":"198","author":"Hassan","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2020.106752_b0070","unstructured":"Hedegaard, H., Mini\u00f1o, A.M., Warner, M (2020). Drug Overdose Deaths in the United States, 1999\u20132018.pdf icon NCHS Data Brief, no 356. Hyattsville, MD: National Center for Health Statistics."},{"key":"10.1016\/j.addbeh.2020.106752_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12888-017-1415-y","article-title":"Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine","volume":"17","author":"Heikman","year":"2017","journal-title":"BMC Psychiatry."},{"issue":"2","key":"10.1016\/j.addbeh.2020.106752_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2020.106752_b0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003\u20132017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.addbeh.2020.106752_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","article-title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","volume":"87","author":"Kerr","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2020.106752_b0095","article-title":"Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration","author":"Lin","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2020.106752_b0100","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"American Journal of Public Health."},{"issue":"1","key":"10.1016\/j.addbeh.2020.106752_b0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: Practical guide for clinicians","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.addbeh.2020.106752_b0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2020.106752_b0115","unstructured":"National Institute on Drug Abuse (2020). Overdose Death Rates. Retrieved from https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates."},{"key":"10.1016\/j.addbeh.2020.106752_b0120","doi-asserted-by":"crossref","unstructured":"Opioids and methamphetamine: a tale of two crises. (2018). Lancet. 391, 713.","DOI":"10.1016\/S0140-6736(18)30319-2"},{"key":"10.1016\/j.addbeh.2020.106752_b0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.addbeh.2020.106752_b0130","doi-asserted-by":"crossref","unstructured":"Robinson, W.T., Kazbour, C., Nassau, T., Fisher, K., Sheu, S., Rivera, A.V. (2020). Brief report: Nonfatal overdose events among persons who inject drugs findings from seven national hiv behavioral surveillance cities 2009 & 2012. Journal of Acquired Immune Deficiency Syndromes. 75, S341\u2013S3S5.","DOI":"10.1097\/QAI.0000000000001426"},{"issue":"6","key":"10.1016\/j.addbeh.2020.106752_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: A systematic review of reviews","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addbeh.2020.106752_b0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.healthplace.2013.11.005","article-title":"Hot spots in mortality from drug poisoning in the United States, 2007\u20132009","volume":"26","author":"Rossen","year":"2014","journal-title":"Health Place."},{"key":"10.1016\/j.addbeh.2020.106752_b0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fnins.2014.00445","article-title":"Impact of methamphetamine on infection and immunity","volume":"8","author":"Salamanca","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.addbeh.2020.106752_b0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2020.106752_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102642","article-title":"Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone","volume":"76","author":"Schneider","year":"2020","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.addbeh.2020.106752_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015\u20132018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2020.106752_b0165","unstructured":"Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https:\/\/www.samhsa.gov\/data\/."},{"issue":"1","key":"10.1016\/j.addbeh.2020.106752_b0170","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18514","article-title":"Evaluation of Trends of Near-Real-Time Urine Drug Test Results for Methamphetamine, Cocaine, Heroin, and Fentanyl","volume":"3","author":"Twillman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.addbeh.2020.106752_b0175","author":"West Virginia Department of Health and Human Resources Bureau for Public Health"},{"key":"10.1016\/j.addbeh.2020.106752_b0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly."},{"key":"10.1016\/j.addbeh.2020.106752_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108113","article-title":"Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: Results from the 2016 National Inpatient Sample","volume":"213","author":"Zhu","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460320308819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460320308819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:43:20Z","timestamp":1759689800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460320308819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":37,"alternative-id":["S0306460320308819"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2020.106752","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of co-occurring substance use in individuals with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2020.106752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106752"}}